cautioning about the use of albumin in seriously ill patients

Experts are now cautioning about the use of albumin in seriously ill patients.

A recent review in the British Medical Journal suggests a 6% HIGHER mortality when albumin is given to patients with hypovolemia...burns...or hypoproteinemia.

This would mean one excess death per 17 treated patients.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote